ASX recovered some lost ground in arvo trade but still finished 0.54% down, as markets continue to be shaken by the discovery of the omicron variant of COVID-19 and falling oil prices.

Resources and tech managed to finish in the green – by 0.74% and 0.59% – but all other sectors were down, led by energy which lost 1.42%.

 

TODAY’S BIGGEST SMALL CAP WINNERS

(Stocks highlighted in yellow rose after making announcements during the trading day).

Scroll or swipe to reveal table. Click headings to sort.

Talon Energy (ASX:TPD) gained after its partner Strike Energy (ASX:STX) released an update on drilling operations at the Walyering-5 well in the Perth Basin.

Strike said final depth of 3,435 metres was reached and positive indications of the presence of gas and conventional quality reservoir was observed.

Goldie Labyrinth Resources (ASX:LRL) hit visible gold, and also hired former Northern Star geology boss Andrew Chirnside as chief mine finder.

 

TODAY’S BIGGEST SMALL CAP LOSERS

(Stocks highlighted in yellow fell after making announcements during the trading day).

Scroll or swipe to reveal table. Click headings to sort.

Short term accomodation provider Allogio (ASX:ALO) fell upon its ASX debut amidst a poor day for the ASX travel sector.

Metal Hawk (ASX:MHK) dropped off the back of an exploration update.

 

ANNOUNCEMENTS YOU MAY’VE MISSED

The ASX welcomed a new ETF in the Perpetual Ethical SRI Fund (ASX:GIVE). It was the first one to be launched by Perpetual and invests in Australian ethically and socially responsible companies.

Agricultural property investor Rural Funds (ASX:RFF), exchanged contracts for a 27,879 hectare cattle and cropping property acquisition. It will pay $17.2 million, 25% of the purchase price, by this month’s end from its debt facility and has negotiated a 24 month settlement for the balance.

Bard1 Life Sciences (ASX:BD1) unveiled plans to develop a exosome-based liquid biopsy in conjunction with Griffith University. It ultimately aims to develop tests to detect breast and ovarian cancers earlier.

Perth apartment builder Finbar (ASX:FRI) received Development Approval for its proposed Garden Towers joint venture flat development. The $207 million development will be 200 metres from the WACA ground and will have 331 apartments and 1,283 square metres of ground floor commercial tenancies.

SME payments business Smartpay (ASX:SMP) unveiled half yearly results for the six months to September 30. The company’s revenue was $21 million, up 45% on the prior corresponding period and its total transaction value in Australia was $1.1 billion which was up 103% year on year.

Biotech Actinogen (ASX:ACW) reached target enrolment in the XanaMIA Part A trial. It will test its lead molecule Xanamem to see if it can improve cognition and results are expected in the second quarter of 2022.

 

TRADING HALTS

Tuesday

Golden Deeps (ASX:GED) – exploration update

Wednesday

Emerald Resources (ASX:EMR) – acquisition
Epsilon Healthcare (ASX:EPN) – Valens agreement update
Leigh Creek Energy (ASX:LCK) – offtake agreement
Vection (ASX:VR1) – capital raising
Firebird Metals (ASX:FRB) – maiden resource estimate